Fox Run Management, L.L.C. Meridian Bioscience Inc Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$13.54 - $26.41 $201,583 - $393,192	-14,888 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$7.84 - $23.29 $116,721 - $346,741	14,888 New	14,888 $347,000
Q4 2017 Jan 18, 2018	SELL	$13.55 - $15.8 $196,475 - $229,100	-14,500 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$13.45 - $14.35 $195,025 - $208,075	14,500	14,500 $207,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.